In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.
Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback